Figure S3. from High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models
View Full Paper
Ask AI
Bookmark
Share
Abstract
CB-011 cells exhibit in vitro antitumor activity against PBMCs from patients with multiple myeloma.
Discussion
No takes yet. Share an insight, caveat, or question.